T1: Post ACS Treatment Tutoring

Slides:



Advertisements
Similar presentations
Acute MI treatment Roger Suss MD CCFP(EM) Lecturer Dept of Family Medicine University of Manitoba.
Advertisements

The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Treatment of Acute Coronary Syndrome with ST elevation ESC guidelines 2008 Dr. David Tran A&E dept. FVH 22/12/09.
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
“ If physicians would read two articles per day out of the six million medical articles published annually, in one year, they would fall 82 centuries behind.
Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
 Randomized controlled trials  Adults ≥ 18 years old with hypertension  N >100  Duration: ≥ 1 year  Outcomes  Mortality, CVD related-mortality,
ACS and Thrombosis in the Emergency Setting
Amy Gutman MD EMS Medication Director
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
Medical Grand Rounds Clinical Vignette October 15 th, 2008 Srikant Duggirala, M.D.
Clopidogrel 75 mg per day orally should be added to aspirin in patients with STEMI regardless of whether they undergo reperfusion.
Clinical Conference 10/23/ y.o. with h/o HTN, presented to Palos ER with SSCP SH: remote tob FH: no early CAD All: NKDA Meds: lisinopril 5mg.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Does early beta-blockade decrease mortality in STEMI?
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Unstable Angina and NSTEMIs: Management Principles Meira Louis Lisa Campfens.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
1 Advanced Angioplasty London, England 27 January, 2006 Jörg Michael Rustige,MD Medical Director Lilly Critical Care Europe, Geneva.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
STEMI ST ELEVATED MYOCARDIAL INFARCTION. TREATMENT Short term desired outcomes: Early restoration to the infarct related artery, to prevent the spread.
GENERAL ORDERS PAGE CATH LAB (*50--State "This is an ALPHA page") AS SOON AS POSSIBLE Complete STEMI Checklist Start 1-2 venous access lines Nasal oxygen.
Acute Coronary Syndrome
+ Therapeutics 1 Tutoring Sarah Darby October 3, 2016.
Drug Induced Liver Disease Tutoring
Therapeutics Tutoring
Objectives Review chest pain Define ACS
Liver Disease tutoring Part 1
Pharmacotherapy Update for STEMI: What Is New?
THE CARDIOVASCULAR EFFECTS OF COCAINE Bryan Schwartz, MD, Shereif Rezkalla, MD, Robert Kloner, MD, PhD.
Cangrelor Case Presentations
Heparin Should be the First-line Therapy for Patients with ACS/AMI
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Liver Disease tutoring Part 2
Coronary artery disease
Acute coronary syndrome
Therapeutics Tutoring
By Saranya Temprasertrudee M.D.
Guidelines for the Management of Patients With ST- Elevation Myocardial Infarction Adapted from Focused Updates: ACC/AHA 2009.
T1: ACS Treatment Tutoring
Management of ST-Elevation Myocardial Infarction
Antiplatelet therapy for STEMI
The European Society of Cardiology Presented by Dr. Saman Rasoul
Ischaemic Heart Disease Acute Coronary Syndrome
HTN Cases Pharmacotherapy - 1.
Coronary artery disease
Brief History on Mission: Lifeline
Unstable Angina and Non–ST Elevation Myocardial Infarction
The Time Dependence of Anti-thrombin Initiation in Patients with Non-ST-segment –elevation Acute Coronary Syndrome: Subgroup Analysis form the ACUITY.
Preventive Angioplasty in Myocardial Infarction Trial
Erasmus MC, Thoraxcenter
© 2004 American Heart Association
Acute Coronary Syndrome (1)
What oral antiplatelet therapy would you choose?
Presents to PCI-capable hospital and undergoes
How would you approach this patient?
Infarct Size after Primary Angioplasty Patients With Bivalirudin
Train-the-Trainer Cases
Management of AMI in patients presenting with STEMI
Train-the-Trainer Cases
Train-the-Trainer Cases
MRRs and EMRRs for women with ACS
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
Presentation transcript:

T1: Post ACS Treatment Tutoring By Alaina Darby

A bit more on immediate therapy… Anti-ischemic Reperfusion

Which of the following should DR not receive? SL Nitroglycerin DR is a 76 yo WM who presents to the ED with chest pain that is diagnosed as STEMI. PMH: diabetes, HTN Vitals/Labs: BP 120/70, HR 96, K 5.1 Which of the following should DR not receive? SL Nitroglycerin IV Nitroglycerine IV morphine PO Metoprolol PO Verapamil D

Why should DR not receive metoprolol? Age >70 SBP <140 DR is a 76 yo WM who presents to the ED with chest pain that is diagnosed as STEMI. PMH: diabetes, HTN Vitals/Labs: BP 120/70, HR 96, K 5.1 Why should DR not receive metoprolol? Age >70 SBP <140 HR <100 Diabetes A

Which may increase mortality in DR? SL Nitroglycerin IV Nitroglycerine DR is a 76 yo WM who presents to the ED with chest pain that is diagnosed as STEMI. PMH: diabetes, HTN Vitals/Labs: BP 120/70, HR 96, K 5.1 Which may increase mortality in DR? SL Nitroglycerin IV Nitroglycerine IV morphine PO Metoprolol PO Verapamil C

DR is a 76 yo WM who presents to the ED with chest pain that is diagnosed as STEMI. PMH: diabetes, HTN Vitals/Labs: BP 120/70, HR 96, K 5.1 Which of the following could be considered an alternative to a beta blocker, since in DR a beta blocker shouldn’t be used? SL Nitroglycerin IV Nitroglycerine IV morphine PO Metoprolol PO Verapamil E

Which of the following would most likely be added to DR’s regimen? DR is a 76 yo WM who presents to the ED with chest pain that is diagnosed as STEMI. PMH: diabetes, HTN Vitals/Labs: BP 120/70, HR 96, K 5.1 Which of the following would most likely be added to DR’s regimen? Lisinopril Carvedilol Verapamil Spironolactone C

What is the door to needle time for tPA? <30 minutes <60 minutes <90 minutes <120 minutes A

What is the door to balloon time for PCI? <30 minutes <60 minutes <90 minutes <120 minutes C

Which of the following is not evidence of successful reperfusion? Relief of chest pain Resolution of ST segment changes Reperfusion arrhythmias Early trough of troponin D

Which of the following patients would be indicated for thrombolytics? 78 yo M with STEMI, presents 6 hours after onset of chest pain, BP 170/100, TIA 6 months prior 22 yo M with NSTEMI, presents 14 hours after onset of chest pain, BP 190/100, no history of TIA 78 yo M with NSTEMI, presents 18 hours after onset of chest pain, BP 170/120, no history of TIA 22 yo M with STEMI, presents 3 hours after onset of chest pain, BP 160/125, no history of TIA A

Which of the following should be given peri-procedurally for PCI? UFH with tirofiban with both infusing for 18-24 hours post procedure UFH with bivalirudin 200 mg load of clopidogrel with 75 mg/day for 12 months 180 mg load of ticagrelor with 90 mg/day for 12 months 60 mg load of prasugrel with 10 mg/day for 12 months ASA 81 mg/day indefinitely E

Stents There was a question about stents last year, so be sure to look over that!! A

Which patient’s RAAS regimen is most indicated? Valsartan for a patient with STEMI and no comorbidities Valsartan for a patient with NSTEMI and no comorbidities Lisinopril for a patient with STEMI and no comorbidities Lisinopril for a patient with NSTEMI and no comorbidities C

Case: FG is a 48 yo WM who presented to the ED with chest pain that was determined to be NSTEMI. PMH: CHF (EF 52), DM SH: smokes ½ ppd, drinks 8 beers/week, denies elicit drug use FH: father died of MI at age 45 Vitals/Labs: K: 6 BP: 140/90 HR: 85

Labetolol, ASA 81 mg, Ticagrelor 90 mg BID FG is a 48 yo WM who presented to the ED with chest pain that was determined to be NSTEMI. PMH: CHF (EF 52), DM SH: smokes ½ ppd, drinks 8 beers/week, denies elicit drug use FH: father died of MI at age 45 Vitals/Labs: K+ 6, BP 140/90, HR 85 What medications should he receive chronically if he does not under go PCI? Labetolol, ASA 81 mg, Ticagrelor 90 mg BID Labetolol, ASA 81 mg, Prasugrel 10 mg Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID Metoprolol, ASA 81 mg, Prasugrel 10 mg C… Labetalol has ISA

Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID, Lisinopril FG is a 48 yo WM who presented to the ED with chest pain that was determined to be NSTEMI. PMH: CHF (EF 52), DM SH: smokes ½ ppd, drinks 8 beers/week, denies elicit drug use FH: father died of MI at age 45 Vitals/Labs: K+ 6, BP 140/90, HR 85 What medications should he receive chronically if he does under go PCI? Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID, Lisinopril Metoprolol, ASA 81 mg, Prasugrel 10 mg, Lisinopril Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID Metoprolol, ASA 81 mg, Prasugrel 10 mg BID C… look at K+!

Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID, Lisinopril FG is a 48 yo WM who presented to the ED with chest pain that was determined to be NSTEMI. PMH: CHF (EF 52), DM SH: smokes ½ ppd, drinks 8 beers/week, denies elicit drug use FH: father died of MI at age 45 Vitals/Labs: K+ 6, BP 140/90, HR 85 FG’s K+ decreases to 3.4 once stabilized. Now, what medications should he receive chronically if he did not under go PCI? Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID, Lisinopril Metoprolol, ASA 81 mg, Prasugrel 10 mg, Lisinopril Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID Metoprolol, ASA 81 mg, Prasugrel 10 mg BID A

FG is a 48 yo WM who presented to the ED with chest pain that was determined to be NSTEMI. PMH: CHF (EF 52), DM SH: smokes ½ ppd, drinks 8 beers/week, denies elicit drug use FH: father died of MI at age 45 Vitals/Labs: K+ 6, BP 140/90, HR 85 FG’s K+ decreases to 3.4 once stabilized. Why should he receive an ACEi? CHF HTN DM HR >75 C

FG is a 48 yo WM who presented to the ED with chest pain that was determined to be NSTEMI. PMH: CHF (EF 52), DM SH: smokes ½ ppd, drinks 8 beers/week, denies elicit drug use FH: father died of MI at age 45 Vitals/Labs: K+ 6, BP 140/90, HR 85 FG’s K+ decreases to 3.4 once stabilized. Which of the following would not confer mortality benefits post-MI? Metoprolol ASA Lisinopril NTG D

Case: HR is a 65 yo AAM who presented to the ED with chest pain that was determined to be STEMI. PMH: CHF (EF 38) Vitals/Labs: K+: 3.9 BP: 120/80 HR: 45

HR is a 65 yo AAM who presented to the ED with chest pain that was determined to be STEMI. PMH: CHF (EF 38) Vitals/Labs: K+ 3.9, BP 120/80, HR 45 What medications should he receive chronically if he does under go PCI? ASA 81 mg, Ticagrelor 90 mg BID ASA 81 mg, Prasugrel 10 mg, Lisinopril Metoprolol, ASA 81 mg, Ticagrelor 90 mg BID, Lisinopril Metoprolol, ASA 81 mg, Prasugrel 10 mg BID, Lisinopril B… look at HR!!

HR is a 65 yo AAM who presented to the ED with chest pain that was determined to be STEMI. PMH: CHF (EF 38) Vitals/Labs: K+ 3.9, BP 120/80, HR 45 HR develops a dry cough, which should be used instead of Lisinopril? Candesartan Losartan Olmesartan Why can’t they use Lisinopril? A

HR is a 65 yo AAM who presented to the ED with chest pain that was determined to be STEMI. PMH: CHF (EF 38) Vitals/Labs: K+ 3.9, BP 120/80, HR 45 Which of the following should be added due to his CHF? Lisinopril Eplenerone ASA A&B All of the above D… ASA is for EVERYONE!!